Cite
PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
MLA
Amos Baruch, et al. PCSK9 Inhibition Alters the Lipidome of Plasma and Lipoprotein Fractions. Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c146d16980dc6d958478d12b9f91279c&authtype=sso&custid=ns315887.
APA
Amos Baruch, Jari Metso, Reijo Laaksonen, Mika Hilvo, Helena Simolin, Matti Jauhiainen, Katariina Öörni, & Maija Ruuth. (2018). PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions.
Chicago
Amos Baruch, Jari Metso, Reijo Laaksonen, Mika Hilvo, Helena Simolin, Matti Jauhiainen, Katariina Öörni, and Maija Ruuth. 2018. “PCSK9 Inhibition Alters the Lipidome of Plasma and Lipoprotein Fractions,” February. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c146d16980dc6d958478d12b9f91279c&authtype=sso&custid=ns315887.